跳至主要内容
临床试验/EUCTR2016-000398-19-BE
EUCTR2016-000398-19-BE进行中(未招募)1 期

Pilot study: pharmacokinetics of beta-lactam antibiotics, piperacillin-tazobactam, ceftazidim and meropenem in blood and sputum of cystic fibrosis patients. - pharmacokinetics of beta-lactam antibiotics, piperacillin-tazobactam, ceftazidim and meropenem

Ghent University0 个研究点目标入组 45 人开始时间: 2016年2月9日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Cystic fibrosis patients who are hospitalized due to pulmonary exacerbation and who will be treated with piperacilin-tazobactam, ceftazidim or meropenem.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 45
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 45
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Age <12 years
  • - Patients not able to produce (enough) sputum
  • - Patients not treated with the antibiotics as mentioned in the inclusion criteria
  • - Patients who underwent a long transplantation
  • - Patients requiring invasive respiration

研究者

相似试验